124 related articles for article (PubMed ID: 32856225)
1. The distinctive characteristics of the micro-vasculature and immune cell infiltration in cystic pancreatic neuroendocrine tumors.
Gao H; Wang W; Zhang W; Xu H; Wu C; Li H; Ni Q; Yu X; Liu L
J Endocrinol Invest; 2021 May; 44(5):1011-1019. PubMed ID: 32856225
[TBL] [Abstract][Full Text] [Related]
2. Are Cystic Pancreatic Neuroendocrine Tumors an Indolent Entity Results from a Single-Center Surgical Series.
Paiella S; Marchegiani G; Miotto M; Malpaga A; Impellizzeri H; Montagnini G; Pollini T; Nessi C; Butturini G; Capelli P; Posenato I; Scarpa A; D'Onofrio M; De Robertis R; Cingarlini S; Boninsegna L; Bassi C; Salvia R; Landoni L
Neuroendocrinology; 2018; 106(3):234-241. PubMed ID: 28586782
[TBL] [Abstract][Full Text] [Related]
3. Role of Tumor-Associated Macrophages in the Clinical Course of Pancreatic Neuroendocrine Tumors (PanNETs).
Cai L; Michelakos T; Deshpande V; Arora KS; Yamada T; Ting DT; Taylor MS; Castillo CF; Warshaw AL; Lillemoe KD; Ferrone S; Ferrone CR
Clin Cancer Res; 2019 Apr; 25(8):2644-2655. PubMed ID: 30670493
[TBL] [Abstract][Full Text] [Related]
4. CD47 expression and CD163
Imam R; Chang Q; Black M; Yu C; Cao W
BMC Cancer; 2021 Mar; 21(1):320. PubMed ID: 33765961
[TBL] [Abstract][Full Text] [Related]
5. Microenvironment and tumor inflammatory features improve prognostic prediction in gastro-entero-pancreatic neuroendocrine neoplasms.
Milione M; Miceli R; Barretta F; Pellegrinelli A; Spaggiari P; Tagliabue G; Centonze G; Paolino C; Mangogna A; Kankava K; Pusceddu S; Giacomelli L; Corti A; Cotsoglou C; Mazzaferro V; Sozzi G; de Braud F; Pruneri G; Anichini A
J Pathol Clin Res; 2019 Oct; 5(4):217-226. PubMed ID: 31136102
[TBL] [Abstract][Full Text] [Related]
6. Tumor-Infiltrating Neutrophils Predict Poor Survival of Non-Functional Pancreatic Neuroendocrine Tumor.
Zhang WH; Wang WQ; Gao HL; Xu SS; Li S; Li TJ; Han X; Xu HX; Li H; Jiang W; Ye LY; Lin X; Wu CT; Yu XJ; Liu L
J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32285127
[TBL] [Abstract][Full Text] [Related]
7. Endoscopic ultrasonography-guided fine-needle aspiration cytology of surgically confirmed cystic pancreatic neuroendocrine tumors: a Mayo Clinic experience.
Chen L; Nassar A; Kommineni VT; Zarka MA; Zhang J; Faigel D; Nguyen C; Halfdanarson TR; Pannala R
J Am Soc Cytopathol; 2015; 4(6):335-343. PubMed ID: 31051748
[TBL] [Abstract][Full Text] [Related]
8. Cystic pancreatic neuroendocrine tumors: the value of cytology in preoperative diagnosis.
Morales-Oyarvide V; Yoon WJ; Ingkakul T; Forcione DG; Casey BW; Brugge WR; Fernández-del Castillo C; Pitman MB
Cancer Cytopathol; 2014 Jun; 122(6):435-44. PubMed ID: 24591417
[TBL] [Abstract][Full Text] [Related]
9. Cystic pancreatic neuroendocrine tumors: endoscopic ultrasound and fine-needle aspiration characteristics.
Yoon WJ; Daglilar ES; Pitman MB; Brugge WR
Endoscopy; 2013; 45(3):189-94. PubMed ID: 23296363
[TBL] [Abstract][Full Text] [Related]
10. Relation of microvessel density with microvascular invasion, metastasis and prognosis in renal cell carcinoma.
Yildiz E; Ayan S; Goze F; Gokce G; Gultekin EY
BJU Int; 2008 Mar; 101(6):758-64. PubMed ID: 18070177
[TBL] [Abstract][Full Text] [Related]
11. Immune landscape, evolution, hypoxia-mediated viral mimicry pathways and therapeutic potential in molecular subtypes of pancreatic neuroendocrine tumours.
Young K; Lawlor RT; Ragulan C; Patil Y; Mafficini A; Bersani S; Antonello D; Mansfield D; Cingarlini S; Landoni L; Pea A; Luchini C; Piredda L; Kannan N; Nyamundanda G; Morganstein D; Chau I; Wiedenmann B; Milella M; Melcher A; Cunningham D; Starling N; Scarpa A; Sadanandam A
Gut; 2021 Oct; 70(10):1904-1913. PubMed ID: 32883872
[TBL] [Abstract][Full Text] [Related]
12. Analysis of Immune Landscape in Pancreatic and Ileal Neuroendocrine Tumours Demonstrates an Immune Cold Tumour Microenvironment.
Tanno L; Naheed S; Dunbar J; Tod J; Lopez MA; Taylor J; Machado M; Green B; Ashton-Key M; Chee SJ; Wood O; Pearce NW; Thomas GJ; Friedmann PS; Cave J; Ottensmeier CH
Neuroendocrinology; 2022; 112(4):370-383. PubMed ID: 34157710
[TBL] [Abstract][Full Text] [Related]
13. Cystic pancreatic neuroendocrine tumors: a clinicopathologic study.
Singhi AD; Chu LC; Tatsas AD; Shi C; Ellison TA; Fishman EK; Kawamoto S; Schulick RD; Wolfgang CL; Hruban RH; Edil BH
Am J Surg Pathol; 2012 Nov; 36(11):1666-73. PubMed ID: 23073325
[TBL] [Abstract][Full Text] [Related]
14. Intratumoral α-SMA enhances the prognostic potency of CD34 associated with maintenance of microvessel integrity in hepatocellular carcinoma and pancreatic cancer.
Wang WQ; Liu L; Xu HX; Luo GP; Chen T; Wu CT; Xu YF; Xu J; Liu C; Zhang B; Long J; Tang ZY; Yu XJ
PLoS One; 2013; 8(8):e71189. PubMed ID: 23940715
[TBL] [Abstract][Full Text] [Related]
15. The comparative study of tumor angiogenesis and CT enhancement in pancreatic carcinoma.
Zhongqiu W; Guangming L; Jieshou L; Xinhua Z; Ziqian C; Kui M
Eur J Radiol; 2004 Mar; 49(3):274-80. PubMed ID: 14962659
[TBL] [Abstract][Full Text] [Related]
16. Microvascular density does not correlate with histopathology and outcome in neuroendocrine tumors of the pancreas.
Tan G; Cioc AM; Perez-Montiel D; Ellison EC; Frankel WL
Appl Immunohistochem Mol Morphol; 2004 Mar; 12(1):31-5. PubMed ID: 15163016
[TBL] [Abstract][Full Text] [Related]
17. Expression of HLA class I/II antigens and T cell immune response in human neuroendocrine tumors of the pancreas.
Ryschich E; Autschbach F; Eisold S; Klar E; Buchler MW; Schmidt J
Tissue Antigens; 2003 Jul; 62(1):48-54. PubMed ID: 12859594
[TBL] [Abstract][Full Text] [Related]
18. Single-cell transcriptomics reveal distinct immune-infiltrating phenotypes and macrophage-tumor interaction axes among different lineages of pituitary neuroendocrine tumors.
Lin S; Dai Y; Han C; Han T; Zhao L; Wu R; Liu J; Zhang B; Huang N; Liu Y; Lai S; Shi J; Wang Y; Lou M; Xie J; Cheng Y; Tang H; Yao H; Fang H; Zhang Y; Wu X; Shen L; Ye Y; Xue L; Wu ZB
Genome Med; 2024 Apr; 16(1):60. PubMed ID: 38658971
[TBL] [Abstract][Full Text] [Related]
19. Microvessel density as a prognostic factor in penile squamous cell carcinoma.
Al-Najar A; Al-Sanabani S; Korda JB; Hegele A; Bolenz C; Herbst H; Jönemann KP; Naumann CM
Urol Oncol; 2012; 30(3):325-9. PubMed ID: 21489377
[TBL] [Abstract][Full Text] [Related]
20. Xenon-inhalation computed tomography for noninvasive quantitative measurement of tissue blood flow in pancreatic tumor.
Kubota M; Murakami T; Nagano H; Eguchi H; Marubashi S; Kobayashi S; Wada H; Tanemura M; Dono K; Nakamori S; Sakon M; Monden M; Mori M; Doki Y
Dig Dis Sci; 2012 Mar; 57(3):801-5. PubMed ID: 21953140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
